Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 299,942 | 66,329 | 50,243 | 35,346 | 61,862 |
| Marketable Securities | 165,115 | 365,343 | 346,019 | 334,740 | 283,665 |
| Receivables | 32,557 | 31,057 | 29,414 | 28,164 | 27,178 |
| Inventories | 6,409 | 6,100 | 6,046 | 5,437 | 5,079 |
| Other current assets | 14,000 | 14,000 | 0 | 0 | 0 |
| TOTAL | $533,893 | $499,253 | $452,402 | $419,045 | $388,220 |
| Non-Current Assets | |||||
| PPE Net | 461 | 633 | 801 | 862 | 726 |
| Investments And Advances | 0 | 4,947 | 4,895 | 11,890 | 22,566 |
| Other Non-Current Assets | 83,494 | 78,597 | 75,157 | 64,567 | 56,611 |
| TOTAL | $83,955 | $84,177 | $80,853 | $77,319 | $79,903 |
| Total Assets | $617,848 | $583,430 | $533,255 | $496,364 | $468,123 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,216 | 11,976 | 8,178 | 8,246 | 9,269 |
| Accrued Expenses | 53,074 | 28,573 | 13,771 | 13,803 | 13,051 |
| Other current liabilities | 14,000 | N/A | N/A | N/A | N/A |
| TOTAL | $78,865 | $72,491 | $53,068 | $49,057 | $57,244 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 552 |
| TOTAL | $9,399 | $9,097 | $6,823 | $4,981 | $3,068 |
| Total Liabilities | $88,264 | $81,588 | $59,891 | $54,038 | $60,312 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 101,578 | 107,899 | 107,650 | 107,105 | 106,251 |
| Common Shares | 131 | 131 | 130 | 128 | 128 |
| Retained earnings | 312,265 | 296,386 | 279,785 | 245,177 | 217,765 |
| Other shareholders' equity | 340 | -1,017 | -2,382 | -1,955 | -1,799 |
| TOTAL | $529,584 | $501,842 | $473,364 | $442,326 | $407,811 |
| Total Liabilities And Equity | $617,848 | $583,430 | $533,255 | $496,364 | $468,123 |